Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency
Authors
Keywords
-
Journal
Nature Communications
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-12-03
DOI
10.1038/ncomms9940
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-22 Suppresses DNA Repair and Promotes Genomic Instability through Targeting of MDC1
- (2015) J.-H. Lee et al. CANCER RESEARCH
- Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation–Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105
- (2015) Melinda L. Telli et al. JOURNAL OF CLINICAL ONCOLOGY
- TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome
- (2015) Sebastian Ribi et al. Oncotarget
- The Fanconi Anemia DNA Repair Pathway: Structural and Functional Insights into a Complex Disorder
- (2014) Helen Walden et al. Annual Review of Biophysics
- Synergistic Activity of PARP Inhibition by Talazoparib (BMN 673) with Temozolomide in Pediatric Cancer Models in the Pediatric Preclinical Testing Program
- (2014) M. A. Smith et al. CLINICAL CANCER RESEARCH
- PyClone: statistical inference of clonal population structure in cancer
- (2014) Andrew Roth et al. NATURE METHODS
- NuMA promotes homologous recombination repair by regulating the accumulation of the ISWI ATPase SNF2h at DNA breaks
- (2014) Pierre-Alexandre Vidi et al. NUCLEIC ACIDS RESEARCH
- Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program:PALB2mutation predicts exceptionalin vivoresponse to BMN 673
- (2014) Malcolm A. Smith et al. PEDIATRIC BLOOD & CANCER
- Digital Expression Profiling Identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as Potential Predictive Biomarkers for Neo-Adjuvant Chemotherapy Response in Paediatric Osteosarcoma
- (2014) Jeffrey W. Martin et al. PLoS One
- Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma
- (2014) Jennifer A. Perry et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
- (2014) Xiang Chen et al. Cell Reports
- Exomic analysis of myxoid liposarcomas, synovial sarcomas, and osteosarcomas
- (2013) Christine G. Joseph et al. GENES CHROMOSOMES & CANCER
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- IntOGen-mutations identifies cancer drivers across tumor types
- (2013) Abel Gonzalez-Perez et al. NATURE METHODS
- Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
- (2012) V Abkevich et al. BRITISH JOURNAL OF CANCER
- Ploidy and Large-Scale Genomic Instability Consistently Identify Basal-like Breast Carcinomas with BRCA1/2 Inactivation
- (2012) T. Popova et al. CANCER RESEARCH
- Mutational Processes Molding the Genomes of 21 Breast Cancers
- (2012) Serena Nik-Zainal et al. CELL
- Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: The molecular choreography
- (2012) Larry H. Thompson MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Molecular subtypes of osteosarcoma identified by reducing tumor heterogeneity through an interspecies comparative approach
- (2011) Milcah C. Scott et al. BONE
- The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo
- (2010) V. J. Weston et al. BLOOD
- Small deletions but not methylation underlie CDKN2A/p16 loss of expression in conventional osteosarcoma
- (2010) Alexander B. Mohseny et al. GENES CHROMOSOMES & CANCER
- IntOGen: integration and data mining of multidimensional oncogenomic data
- (2010) Gunes Gundem et al. NATURE METHODS
- Rare, Evolutionarily Unlikely Missense Substitutions in ATM Confer Increased Risk of Breast Cancer
- (2009) Sean V. Tavtigian et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Synthetic lethal targeting ofPTENmutant cells with PARP inhibitors
- (2009) Ana M. Mendes-Pereira et al. EMBO Molecular Medicine
- PTEN: a new guardian of the genome
- (2008) Y Yin et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search